Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00025662
Status:
COMPLETED
Last Update Posted:
2016-10-28
First Post:
2001-10-11
Brief Title:
Selective T-Cell Depletion to Reduce GVHD Patients Receiving Stem Cell Tx to Treat Leukemia Lymphoma or MDS
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Institutes of Health Clinical Center CC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hodgkin Disease |
| Graft vs Host Disease |
| Myelodysplastic Syndromes |
| Leukemia |
| Leukemia Myeloid |
| Leukemia Myelomonocytic Chronic |
| Leukemia Lymphocytic |
| Lymphoma |
| Lymphoma Mantle-cell |
| Lymphoma Non-Hodgkin |
Keywords:
| Name | View |
|---|---|
| Bone Marrow Transplant | View |
| Peripheral Blood Stem Cell | View |
| Melphalan | View |
| Fludarabine | View |
| Donor Apheresis | View |
| Non-Myeloablative | View |
| MDS | View |
| Chronic Myeloid Leukemia | View |
| CML | View |
| Chronic Lymphocytic Leukemia | View |
| CLL | View |
| Lymphoma | View |
| Non-Hodgkins Lymphoma | View |
| Hodgkins Disease | View |
| Mantle Cell Lymphoma | View |
| Acute Myelogenous Leukemia AML | View |
| Chronic Myeloid Leukemia CML | View |
| Chronic Lymphocytic Leukemia CLL | View |
| Myelodysplasia MDS | View |
| Acute Lymphoblastic Leukemia ALL | View |